Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study

NCT06605326 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Pulmonary Arterial Hypertension
Chronic Lung Disease-Associated Pulmonary Hypertension
Lung Transplantation
Heart Failure

Interventions

DRUG: Subcutaneous Treprostinil

Sponsor

Guangzhou Institute of Respiratory Disease